Mattsson, J <br/><br/>
A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate.  [electronic resource] 

 -  Transplantation proceedings   
 - 735-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/s0041-1345(96)00444-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Antilymphocyte Serum--therapeutic use<br/>Bone Marrow Transplantation--immunology<br/>Communicable Diseases--mortality<br/>Cyclosporine--therapeutic use<br/>Graft vs Host Disease--epidemiology<br/>HLA-A Antigens<br/>HLA-B Antigens<br/>HLA-DR Antigens<br/>Histocompatibility Testing<br/>Humans<br/>Immunosuppression Therapy--methods<br/>Immunosuppressive Agents--therapeutic use<br/>Incidence<br/>Leukemia--therapy<br/>Living Donors<br/>Lymphoma--therapy<br/>Metabolism, Inborn Errors--therapy<br/>Methotrexate--therapeutic use<br/>Multiple Myeloma--therapy<br/>Myelodysplastic Syndromes--therapy<br/>Nuclear Family